How Risky Is Myriad Genetics Stock?


That's not really how the old adage goes, but the changed wording just might be applicable to Myriad Genetics . Shares of the molecular diagnostics testing company took a beating during the first few months of 2016, losing over 20% of its market value.



from Biotech News